Search Contract Opportunities

Battlefield Wound Infection Prevention and Treatment (BWI P&T): Barrier Combination Product Development

ID: HT9427-26-RFI-BWI-PT • Type: Sources Sought • Match:  90%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:

Description

The Government is conducting market research to determine whether a commercial solution can be provided to meet requirements for battlefield wound infection prevention and treatment: barrier combination product. This market research may also assist with the further development and/or refinement of the requirements.

Objective and Purpose/Scope: DHA's OPMED WPAC has a requirement to develop, deliver, and field medical products that address battlefield wounds and subsequent bacterial and fungal infections. The Battlefield Wound Infection Prevention and Treatment (BWI P&T) program is using a Family of Systems (FoS) approach that aims to develop multiple medical materiel solutions that are most relevant for use in austere environments where medical products may be limited and evacuation may be prolonged.

This RFI seeks responses to the barrier combination component of this FoS only.

Although there is an emphasis on use at the point of injury, this capability will likely be used across roles

of care spanning the austere battlefield environment to hospital care settings. The barrier combination product is

expected to be one of many components of the FoS that will provide novel solutions to the DoD and commercial

market with respect to wound care and infection prevention.

The barrier combination product must have the following minimum essential characteristics:

Please refer to Attachment 3 - Minimum Essential Characteristics (MECS)

North American Industry Classification System (NAICS) Code: Unknown

RFI Attachments: The following documents are attached to the RFI

  • Attachment 1: Technical Readiness Level (TRL) (Reference Only)
  • Attachment 2: Company & Product Information
  • Attachment 3: Minimum Essential Characteristics (MECS)
  • Response Due Date: Interested parties shall submit the RFI response electronically by 2:00pm Eastern on January 20, 2026, via e-mail to:

Please review Attachments 1, 2, and 3 as well as RFI for BWI PT Barrier Attachment for further instructions

Background
The Defense Health Agency (DHA) is conducting market research to explore commercial solutions for battlefield wound infection prevention and treatment, specifically focusing on a barrier combination product. This initiative aims to refine requirements for medical products that address battlefield wounds and subsequent infections, utilizing a Family of Systems (FoS) approach to develop multiple medical materiel solutions suitable for austere environments where medical resources may be limited.

Work Details
The Battlefield Wound Infection Prevention and Treatment (BWI P&T) program requires the development, delivery, and fielding of medical products that effectively address battlefield wounds and prevent bacterial and fungal infections. The focus is on the barrier combination component of the FoS, which is intended for use at the point of injury and across various care roles from austere battlefield settings to hospital environments.

The barrier combination product must meet specific minimum essential characteristics outlined in Attachment 3 - Minimum Essential Characteristics (MECS).

Place of Performance
The contract will be performed at locations relevant to the Defense Health Agency's operations, primarily in Frederick, MD (on Fort Detrick).
Show All

Overview

Agency
Defense Health Agency (DHA) [DoD]
Response Deadline
Jan. 20, 2026, 2:00 p.m. EST Past Due
Posted
Dec. 3, 2025, 11:44 a.m. EST
Set Aside
None
NAICS
None
PSC
None
Place of Performance
MD 21702 United States
Source
Open
Est. Level of Competition
Average
Odds of Award
20%
On 12/3/25 Defense Health Agency issued Sources Sought HT9427-26-RFI-BWI-PT for Battlefield Wound Infection Prevention and Treatment (BWI P&T): Barrier Combination Product Development due 1/20/26.
Primary Contact
Name
Jeanette Collins   Profile
Email
jeanette.m.collins4.civ@health.mil
Phone
None

Secondary Contact

Name
Julie Burns   Profile
Email
julia.l.burns3.civ@health.mil
Phone
None

Documents

Posted documents for Sources Sought HT9427-26-RFI-BWI-PT

Opportunity Assistant

AI Analysis
AI Generate

Incumbent or Similar Awards

Contracts Similar to Sources Sought HT9427-26-RFI-BWI-PT

Potential Bidders and Partners

Awardees that have won contracts similar to Sources Sought HT9427-26-RFI-BWI-PT

Similar Active Opportunities

Open contract opportunities similar to Sources Sought HT9427-26-RFI-BWI-PT

Experts for Battlefield Wound Infection Prevention and Treatment (BWI P&T): Barrier Combination Product Development

Recommended subject matter experts available for hire

Additional Details

Source Agency Hierarchy
DEPT OF DEFENSE > DEFENSE HEALTH AGENCY (DHA) > DEFENSE HEALTH AGENCY
FPDS Organization Code
97DH-HT9427
Source Organization Code
500196163
Last Updated
Feb. 5, 2026
Last Updated By
jeanette.m.collins4.civ@health.mil
Archive Date
Feb. 4, 2026